Market Place
Sourcing Support
All News #Library
Biotech
FDA Grants Innocan Third Consecutive Fee Waiver In 2026
27 Feb 2026 //
PR NEWSWIRE
Innocan Pharma Shows LPT-CBD Pain Relief In Dogs Study
09 Feb 2026 //
PR NEWSWIRE
Innocan Reports Strong Pain Relief Data For LPT-CBD In Goats
24 Nov 2025 //
PR NEWSWIRE
Innocan Reveals Positive LPT-CBD Results In Gottingen Minipigs
20 Nov 2025 //
PR NEWSWIRE
Liposomal CBD Injection Technology Patent Was Allowed in Japan
15 Oct 2025 //
PR NEWSWIRE BIO
Innocan’s Liposomal CBD Tech Gains Attention at PAINWeek
15 Sep 2025 //
PR NEWSWIRE
Innocan`s Findings Featured at PAINWeek2025 Conference, Las Vegas
23 Aug 2025 //
PR NEWSWIRE
Innocan: Promising LPT-CBD Results in Minipigs, Update Shared
03 Jul 2025 //
PR NEWSWIRE
Innocan’s BI Sky Global Completes HRIPT, Hits Sales Milestone
29 Jan 2025 //
PR NEWSWIRE
Innocan Shares 2024 Research And Development Annual Update
12 Dec 2024 //
PR NEWSWIRE
Innocan Pharma Reports Positive Safety Results with LPT-CBD
26 Nov 2024 //
PR NEWSWIRE
Innocan Focuses on Positive FDA Engagement & Market Potential
11 Nov 2024 //
PR NEWSWIRE
Innocan`s LPT-CBD Shows Success in Osteoarthritis Pain in Dogs
11 Oct 2024 //
PR NEWSWIRE
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
29 Aug 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.